GGrantIndex
Sort

25,944 grants matching neurodegeneration

TMEM230 and Neurodegeneration in Parkinson's Disease

$336,226
Xugang Xia · Florida International University · R01 · FY2024 · NS

Complement-Microglia Interaction in Synaptic Loss and Neurodegeneration in HD

$336,200
Xiangdong William Yang · University Of California Los Angeles · R01 · FY2014 · NS

Abeta and Monoaminergic Neurodegeneration in Transgenic Mouse Models of AD

$336,200
Michael K Lee · Johns Hopkins University · R01 · FY2009 · AG

Corticolimbic Degeneration and Treatment of Dementia

$336,188
John G Csernansky · Northwestern University At Chicago · R01 · FY2009 · MH

DNA Damage and Neurodegeneration in Cockayne Syndrome

$336,178
James E Cleaver · University Of California, San Francisco · R01 · FY2007 · NS

LRRK2 and Neurodegeneration

$336,167
Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2013 · NS

Structure/Function of Complex II Oxidoreductase

$336,123
Gary Cecchini · Northern California Institute/Res/Edu · R01 · FY2011 · GM

Structure/Function of Complex II Oxidoreductase

$336,123
Gary Cecchini · Northern California Institute/Res/Edu · R01 · FY2012 · GM

Mechanisms of Manganese Neurotoxicity

$336,108
Michael Aschner · Vanderbilt University · R01 · FY2009 · ES

Mechanisms of Manganese Neurotoxicity

$336,108
Michael Aschner · Vanderbilt University · R01 · FY2008 · ES

Molecular Mechanisms and Functions of Mitochondrial Ca2+ transport in Neurons

$336,099
Yuriy M Usachev · University Of Iowa · R01 · FY2019 · NS

Sensory and Motor Streams in Preclinical and Clinical Stages of Alzheimer's Disease

$336,000
Jorge Sepulcre · Massachusetts General Hospital · R01 · FY2019 · AG

Sensory and Motor Streams in Preclinical and Clinical Stages of Alzheimer's Disease

$336,000
Jorge Sepulcre · Massachusetts General Hospital · R01 · FY2021 · AG

Evaluating diverse technologies for detecting and validating senescent cells in vivo

$336,000
Simon Melov · Buck Institute For Research On Aging · UG3 · FY2021 · CA

Sensory and Motor Streams in Preclinical and Clinical Stages of Alzheimer's Disease

$336,000
Jorge Sepulcre · Massachusetts General Hospital · R01 · FY2022 · AG

Quantifying the Influence of Pathological Hemodynamics on Cerebral Microvascular Dysfunction and Neuronal Injury

$336,000
John Hundley Slater · University Of Delaware · P20 · FY2024 · GM

Sensory and Motor Streams in Preclinical and Clinical Stages of Alzheimer's Disease

$336,000
Jorge Sepulcre · Massachusetts General Hospital · R01 · FY2020 · AG

Multiple Approaches to Abeta Vaccination in Animal Models

$335,943
David Hastings Cribbs · University Of California-Irvine · R01 · FY2012 · AG

Cognitive Assessment and Adjudication Core

$335,934
Terry Goldberg · Columbia University Health Sciences · U19 · FY2025 · AG

GSK3beta, a mediator of ethanol neurotoxicity

$335,898
Jia Luo · University Of Kentucky · R01 · FY2018 · AA

Non-Invasive Monitoring of NPC Disease Progression and Therapy

$335,898
Theodore P Trouard · University Of Arizona · R01 · FY2008 · EB

GSK3beta, a mediator of ethanol neurotoxicity

$335,898
Jia Luo · University Of Kentucky · R01 · FY2017 · AA

GSK3beta, a mediator of ethanol neurotoxicity

$335,898
Jia Luo · University Of Kentucky · R01 · FY2016 · AA

Astroglial Monocarboxylate Transporter (MCT) Pathway in Neurodegeneration

$335,832
Jeffrey D Rothstein · Johns Hopkins University · R01 · FY2013 · NS

Epigenetic Regulation of Germ Cell Differentiation from a Stem Cell Lineage

$335,832
Xin Chen · Johns Hopkins University · R01 · FY2021 · HD